Desloratadine: A new, nonsedating, oral antihistamine

This publication has 19 references indexed in Scilit:

• Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine
  Clinical and Experimental Allergy, 2001
• Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice Commentary: Reporting of adverse events is worth the effort
  BMJ, 2000
• Consensus statement * on the treatment of allergic rhinitis
  Allergy, 2000
• Allergic Rhinitis: Epidemiology and Natural History
  Allergy and Asthma Proceedings, 2000
• Second-generation antihistamines: The risk of ventricular arrhythmias
  Clinical Therapeutics, 1999
• Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
  Annals of Allergy, Asthma & Immunology, 1998
• Loratadine and desethoxylcarbonyl‐loratadine inhibit the immunological release of mediators from human FcɛRI⁺cells
  Clinical and Experimental Allergy, 1997
• Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines
  Experimental Dermatology, 1995
• Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells
  Allergy, 1995
• Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine
  Inflammation Research, 1984